Q2 FY26 results: Revenue down 13% YoY, PAT down 35% standalone
BHARATRAS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 6.1 pts less than Nifty Microcap 250 and 5.5 pts less than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Bharat Rasayan reported Q2 FY26 standalone revenue of about Rs 28,596 lacs, down 13% from Rs 32,787 lacs last year. Standalone PAT fell 35% to Rs 2,616 lacs versus Rs 4,015 lacs. For the six months, revenue grew 9% to Rs 66,336 lacs and PAT rose 4% to Rs 6,982 lacs. Results include an exceptional item of Rs 1,478 lacs booked in Q1. Insurance claim process for plant damage at Dahej continues. Limited review carried out by B.K. Goel and Associates.
Q2 weakness in revenue and profit may concern investors despite decent H1 growth. Dahej claim outcome and exceptional items worth tracking.